Skip to content
2000
Volume 5, Issue 1
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

Background

D. Don is a Chinese herb, that belongs to the family Lamiaceae. It has established traditional use in ethnomedicine for treating various ailments, including mood disorders and sleep disorders, which led to growing interest in exploring its neurological potential, particularly as a potential anti-depressant agent.

Aims

This study explores the anti-depressant potential of the HSBE utilizing a Chronic Unpredictable Mild Stress-induced depression model in mice. Additionally, the research aims to elucidate the underlying mechanisms of action.

Methods

Swiss albino mice were subjected to a 3-week CUMS paradigm and subsequently administered HSBE at doses of 200 and 400 mg/kg oral administration. The behavioral alterations were evaluated using the FST, TST, OFT, and SPT. Brain levels of serotonin, dopamine, and nor-epinephrine were estimated in different brain regions (cortex, hippocampus, and hypothalamus) to uncover the molecular mechanism. Additionally, assays for monoamine oxidase-A, monoamine oxidase-B, and antioxidant enzyme activities were conducted. Plasma nitrite and corticosterone levels were also measured to get further insight into potential mechanisms underlying the anti-depressant effects of HSBE.

Results

HSBE significantly ameliorated depressive-like behavior induced by CUMS paradigm, as evidenced by reduced immobility in FST and TST, increased locomotor activity in OFT, and improved sucrose preference in SPT. Neurochemical analysis revealed a significant increase in serotonin, dopamine, and norepinephrine levels in the cortex, hippocampus, and hypothalamus of HSBE-treated mice, implying a potential regulation of monoaminergic neurotransmitter levels. Moreover, biochemical analyses demonstrated a significant inhibition of both MAO-A and MAO-B activity, contributing to the increase of the brain levels of neurotransmitters. The administration of HSBE also led to a significant enhancement of antioxidant enzyme activities and reduced brain lipid peroxidation, indicating a pronounced antioxidant effect of HSBE. Furthermore, decreased plasma nitrite and corticosterone levels provided additional insights into HSBE's potential multi-targeted anti-depressant mechanism.

Conclusion

This study indicates that HSBE exhibits robust anti-depressant properties, supported by behavioral, neurochemical, and biochemical alterations. These findings underscore the therapeutic promise of HSBE as a natural intervention for depressive disorders, warranting further clinical exploration.

Loading

Article metrics loading...

/content/journals/cnt/10.2174/0126659786304405240709114804
2024-08-06
2024-12-25
Loading full text...

Full text loading...

References

  1. World Health Organization.2023Available from: https://www.who.int/news-room/fact-sheets/detail/depression
  2. WoodyC.A. FerrariA.J. SiskindD.J. WhitefordH.A. HarrisM.G. A systematic review and meta-regression of the prevalence and incidence of perinatal depression.J. Affect. Disord.2017219869210.1016/j.jad.2017.05.003 28531848
    [Google Scholar]
  3. FergusonJ.M. SSRI antidepressant medications: Adverse effects and tolerability.Prim. Care Companion J. Clin. Psychiatry2001312227 15014625
    [Google Scholar]
  4. BraundT.A. TillmanG. PalmerD.M. GordonE. RushA.J. HarrisA.W.F. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: An iSPOT-D report.Transl. Psychiatry202111141710.1038/s41398‑021‑01533‑1 34349116
    [Google Scholar]
  5. SahaK. TorousJ. KicimanE. De ChoudhuryM. Understanding side effects of antidepressants: Large-scale longitudinal study on social media data.JMIR Ment. Health202183e2658910.2196/26589 33739296
    [Google Scholar]
  6. ChenQ. RahmanK. WangS.J. ZhouS. ZhangH. Scutellaria barbata: A review on chemical constituents, pharmacological activities and clinical applications.Curr. Pharm. Des.202026116017510.2174/1381612825666191216124310 31840605
    [Google Scholar]
  7. WangL. ChenW. LiM. ZhangF. ChenK. ChenW. A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D.Don. J. Ethnopharmacol.202025411226010.1016/j.jep.2019.112260 31577937
    [Google Scholar]
  8. PannuA. GoyalR.K. Pharmacognostical characterization of whole scutellaria barbata herb for quality control assessment.Innovat Int J Medical & Pharma Sci.20216415
    [Google Scholar]
  9. PannuA. GoyalR.K. Safety study of hydroethanol extract of scutellaria barbata d. Don in albino swiss mice as per OECD guidelines 425.Innovat Int J Medical & Pharma Sci.2022721621
    [Google Scholar]
  10. DhingraD. BhankherA. Behavioral and biochemical evidences for antidepressant-like activity of palmatine in mice subjected to chronic unpredictable mild stress.Pharmacol. Rep.20146611910.1016/j.pharep.2013.06.001 24905299
    [Google Scholar]
  11. DhingraD. DeepakD. Antidepressant-like activity of flowers of Tecomella undulata in mice subjected to chronic unpredictable mild stress.Asian J. Pharm. Clin. Res.201912113013810.22159/ajpcr.2019.v12i1.28981
    [Google Scholar]
  12. DhingraD. ValechaR. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests.Med. Sci. Monit.2007137BR155BR161 17599020
    [Google Scholar]
  13. CharlesM. McEwanJ. MAO activity in rabbit serum.Methods in enzymologyAcademic Press: New York and London1977XVIIB692698
    [Google Scholar]
  14. SchurrA. LivneA. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components.Biochem. Pharmacol.197625101201120310.1016/0006‑2952(76)90369‑5 938542
    [Google Scholar]
  15. StahlW. SiesH. β-Carotene and other carotenoids in protection from sunlight.Am. J. Clin. Nutr.20129651179S1184S10.3945/ajcn.112.034819 23053552
    [Google Scholar]
  16. MisraH.P. FridovichI. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.J. Biol. Chem.1972247103170317510.1016/S0021‑9258(19)45228‑9 4623845
    [Google Scholar]
  17. AebiH. Catalase in vitro.Methods Enzymol.198410512112610.1016/S0076‑6879(84)05016‑3 6727660
    [Google Scholar]
  18. OhkawaH. OhishiN. YagiK. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal. Biochem.197995235135810.1016/0003‑2697(79)90738‑3 36810
    [Google Scholar]
  19. GreenL.C. WagnerD.A. GlogowskiJ. SkipperP.L. WishnokJ.S. TannenbaumS.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.Anal. Biochem.1982126113113810.1016/0003‑2697(82)90118‑X 7181105
    [Google Scholar]
  20. BartosJ. PesezM. Colorimetric and fluorimetric determination of steroids.Pure Appl. Chem.197951102157216910.1351/pac197951102157
    [Google Scholar]
  21. CryanJ.F. MarkouA. LuckiI. Assessing antidepressant activity in rodents: Recent developments and future needs.Trends Pharmacol. Sci.200223523824510.1016/S0165‑6147(02)02017‑5 12008002
    [Google Scholar]
  22. DetkeM.J. RickelsM. LuckiI. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.Psychopharmacology19951211667210.1007/BF02245592 8539342
    [Google Scholar]
  23. HaslerG. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians?World Psychiatry20109315516110.1002/j.2051‑5545.2010.tb00298.x 20975857
    [Google Scholar]
  24. ZakariaF.H. SamhaniI. MustafaM.Z. ShafinN. Pathophysiology of depression: Stingless bee honey promising as an antidepressant.Molecules20222716509110.3390/molecules27165091 36014336
    [Google Scholar]
  25. TianH. HuZ. XuJ. WangC. The molecular pathophysiology of depression and the new therapeutics.MedComm202233e15610.1002/mco2.156 35875370
    [Google Scholar]
  26. KatrenčíkováB. VavákováM. PaduchováZ. NagyováZ. GaraiovaI. MuchováJ. ĎuračkováZ. TrebatickáJ. Oxidative stress markers and antioxidant enzymes in children and adolescents with depressive disorder and impact of omega-3 fatty acids in randomised clinical trial.Antioxidants2021108125610.3390/antiox10081256 34439504
    [Google Scholar]
  27. VargheseF.P. BrownE.S. The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care physicians.Prim. Care Companion J. Clin. Psychiatry200134151155 15014598
    [Google Scholar]
/content/journals/cnt/10.2174/0126659786304405240709114804
Loading
/content/journals/cnt/10.2174/0126659786304405240709114804
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test